CASE REPORT
Accepted on 02 Sep 2025
Safety and Efficacy Assessment of Teclistamab in Relapsed/Refractory Amyloidosis: A Case Study
doi 10.3389/fonc.2025.1664171
- 184 views
- Frontiers in Oncology
- Hematologic Malignancies
- Research Topics
- Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
Chimeric Antigen Receptor T Cell Therapies and Bispecific Antibodies in Hematologic Malignancies
1,419
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.